M
Michael J. Ackerman
Researcher at Mayo Clinic
Publications - 802
Citations - 48481
Michael J. Ackerman is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Long QT syndrome & QT interval. The author has an hindex of 112, co-authored 683 publications receiving 41727 citations. Previous affiliations of Michael J. Ackerman include Boston Children's Hospital & The Advisory Board Company.
Papers
More filters
Journal ArticleDOI
Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation
Barry J. Maron,Paul D. Thompson,Michael J. Ackerman,Gary J. Balady,Stuart Berger,David Cohen,Robert J. Dimeff,Pamela S. Douglas,David W. Glover,Adolph M. Hutter,Michael D. Krauss,Martin S. Maron,Matthew J. Mitten,William O. Roberts,James C. Puffer +14 more
TL;DR: The increasing awareness that automated external defibrillators may not always prove successful in the secondary prevention of sudden death for athletes with cardiovascular disease underscores the importance of preparticipation screening for the prospective identification of at-risk athletes and the prophylactic prevention of cardiac events during sports by selective disqualification.
Journal ArticleDOI
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
Barbara J. Drew,Michael J. Ackerman,Marjorie Funk,W. Brian Gibler,Paul Kligfield,Venu Menon,George J. Philippides,Dan M. Roden,Wojciech Zareba +8 more
TL;DR: In this paper, the authors discuss the risk of cardiac arrest due to torsade de pointes (TdP) in the acquired form of drug-induced long-QT syndrome (LQTS) is a rare but potentially catastrophic event in hospital settings.
Journal ArticleDOI
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
Steve R. Ommen,Barry J. Maron,Iacopo Olivotto,Martin S. Maron,Franco Cecchi,Sandro Betocchi,Bernard J. Gersh,Michael J. Ackerman,Robert B. McCully,Joseph A. Dearani,Hartzell V. Schaff,Gordon K. Danielson,A. Jamil Tajik,Rick A. Nishimura +13 more
TL;DR: Surgical myectomy performed to relieve outflow obstruction and severe symptoms in HCM was associated with long-term survival equivalent to that of the general population, and superior to obstructive HCM without operation.
Journal ArticleDOI
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
Jamie D. Kapplinger,David J. Tester,Marielle Alders,Begoña Benito,Myriam Berthet,Josep Brugada,Pedro Brugada,Véronique Fressart,Alejandra Guerchicoff,Carole Harris-Kerr,Shiro Kamakura,Florence Kyndt,Florence Kyndt,Tamara T. Koopmann,Yoshihiro Miyamoto,Ryan Pfeiffer,Guido D. Pollevick,Vincent Probst,Sven Zumhagen,Matteo Vatta,Jeffrey A. Towbin,Wataru Shimizu,Eric Schulze-Bahr,Charles Antzelevitch,Benjamin A. Salisbury,Pascale Guicheney,Arthur A.M. Wilde,Ramon Brugada,Jean-Jacques Schott,Jean-Jacques Schott,Jean-Jacques Schott,Michael J. Ackerman +31 more
TL;DR: Overall, 21% of BrS probands have mutations in SCN5A compared to the 2% to 5% background rate of rare variants reported in healthy control subjects, which may help further distinguish pathogenic mutations from similarly rare but otherwise innocuous ones found in cases.
Journal ArticleDOI
The visible human male: a technical report.
TL;DR: The National Library of Medicine's Visible Human Male data set consists of digital magnetic resonance (MR), computed tomography (CT), and anatomic images derived from a single male cadaver.